Advertisement
Australia markets closed

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • AUD/USD

    0.6425
    -0.0000 (-0.00%)
     

  • OIL

    82.78
    +0.05 (+0.06%)
     

  • GOLD

    2,396.80
    -1.20 (-0.05%)
     

  • Bitcoin AUD

    101,183.95
    +3,582.20 (+3.67%)
     

  • CMC Crypto 200

    1,383.19
    +70.56 (+5.69%)
     

  • AUD/EUR

    0.6019
    -0.0012 (-0.20%)
     

  • AUD/NZD

    1.0891
    +0.0017 (+0.15%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,308.83
    -85.48 (-0.49%)
     

  • FTSE

    7,852.99
    -24.06 (-0.31%)
     

  • Dow Jones

    37,985.49
    +210.11 (+0.56%)
     

  • DAX

    17,754.73
    -82.67 (-0.46%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Company News for Sep 23, 2019

Zacks Equity Research

  • Shares of McDermott International, Inc. MDR gained 27.2% after the engineering and construction services provider to the energy industry said that it was exploring the sale of its Lummus Technology business.

  • Shares of Merck & Co., Inc. MRK rose 1.4% after the FDA approved the company’s drugs Pifeltro and Delstrigo for “virally suppressed” HIV-1 patients.

  • Shares of Netflix, Inc. NFLX declined 5.5% after CEO Reed Hastings warned of tough competition from Apple and Disney.

  • Shares of Xilinx, Inc. XLNX dropped 6.8% after the chipmaker’s CFO Lorenzo Flores said he was stepping down.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Netflix, Inc. (NFLX) : Free Stock Analysis Report
 
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
 
McDermott International, Inc. (MDR) : Free Stock Analysis Report
 
Xilinx, Inc. (XLNX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research